Maryland Stem Cell Research Commission Funds 36 New Projects In FY 2011
As highlighted in its 2011 RFAs, the Commission gave preference to proposals that focus on advancing regenerative medicine, by selecting promising research that addresses osteoporosis, traumatic brain injuries, heart disease, cancer, diabetes, schizophrenia, ALS, autism, DNA damage, intestinal tissue generation, clinical drug screenings, and other debilitating and costly medical conditions. This funding cycle, the Commission also encouraged collaborations, resulting in 10 awardees (more than 25 percent) proposing to work with private biotech companies. In a groundbreaking new pilot program, two MSCR funded researchers will collaborate with scientists funded by the California Institute of Regenerative Medicine (CIRM). These two projects, studying red blood cell production and traumatic axonal injuries, will leverage Maryland's investment in stem cell research with more than $7 million in CIRM funding.
"Each year, Maryland's stem cell research program is a national leader in research and innovation while creating jobs and stimulating our State economy," said Governor Martin O'Malley. "I'd like to congratulate this year's awardees, and we look forward to their contributions to the field."
This year's MSCRF awards include:
-- 9 Investigator-Initiated Research Grants (RFA-MD-11-01) - providing up to $200,000 of direct costs per year, for up to three years, to investigators with preliminary data to support their hypotheses;
-- 3 Exploratory Research Grants (RFA-MD-11-02) - providing up to $100,000 of direct costs per year, for up to two years, to new stem cell researchers (young investigators and scientists from other fields), for new approaches, mechanisms or models that may differ from current thinking in the field and/or new hypotheses that have little or no preliminary data; and
-- 14 Post-Doctoral Fellowship Research Grants (RFA-MD-11-03) - providing up to $55,000 per year, for up to two years, including direct and indirect costs and fringe benefits, to post-doctoral fellows.
All MSCRF-funded research must be conducted in Maryland, and must involve human stem cells.
Source: Maryland Stem Cell Research Commission
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Maryland Stem Cell Research Commission. "Maryland Stem Cell Research Commission Funds 36 New Projects In FY 2011." Medical News Today. MediLexicon, Intl., 27 May. 2011. Web.
26 May. 2017. <http://www.medicalnewstoday.com/releases/226684.php>
Maryland Stem Cell Research Commission. (2011, May 27). "Maryland Stem Cell Research Commission Funds 36 New Projects In FY 2011." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.